Gangliosidosis (GM1) |
approved
|
230500 |
|
Gastrointestinal defects and immunodeficiency syndrome (GIDID) |
approved
|
243150 |
|
|
Gaucher Disease Type II |
approved
|
230900 |
|
Gaucher Disease Type III |
approved
|
231000 |
|
|
Generalized epilepsy with febrile seizures plus, type 1 (GEFSP1) |
approved
|
604233 |
|
|
Generalized epilepsy with febrile seizures plus, type 2 (GEFSP2) |
approved
|
604403 |
|
|
Generalized epilepsy with febrile seizures plus, type 3 (GEFSP3) |
approved
|
607681 |
|
|
Generalized epilepsy with febrile seizures plus, type 5, susceptibility to, (GEFSP5) |
approved
|
613060 |
|
|
Geroderma Osteodysplasticum |
approved
|
231070 |
|
|
Gerstmann-Straussler-Scheinker syndrome |
approved
|
137440 |
|
|
Glanzmann Thrombasthenia |
approved
|
273800 |
|
|
Glutaric Acidemia (aciduria) |
approved
|
231670 |
|
Glycogen Storage Disease II (Pompe Disease (early onset)) (GSD2) |
approved
|
232300 |
|
Glycogen storage disease IXa1 (GSD9A1) |
approved
|
306000 |
|
|
Glycogen storage disease IXa2 (GSD9A2) |
approved
|
306000 |
|
Glycogen storage disease IXb (GSD9B) |
approved
|
261750 |
|
|
Glycogen storage disease IXc (GSD9C) |
approved
|
613027 |
|
|
Glycogen storage disease IXd (GSD9D) |
approved
|
300559 |
|
|
Glycogen storage disease type 1B |
approved
|
232220 |
|
|
Glycogen Storage Disease Type 3 |
approved
|
232400 |
|
|